Innovative analytical methods for particulate characterization

Manufacturers respond to stricter regulations with novel approaches.

Read more

Swedish researchers find new pain organ

Researchers at Karolinska Institutet have discovered a new sensory receptor organ that is able to detect painful mechanical damage, such as pricks and impacts.

Read more

Researchers unravel potential cancer target

British researchers have found out what’s going wrong with chromosome segregation in some cancers. 

Read more

Pharming licenses orphan drug from Novartis

Pharming NV has paid €17.9m upfront to Novartis AG for an exclusive license to CDZ173, a late stage drug for the treatment of APDS
Read more

New stem cell population may help repair teeth

Researchers have discovered that crosstalk of a newly discovered stem cell population with quiescent stem cells may help repair teeth in the future.

Read more

Bayer bags iPSC specialist BlueRock Therapeutics

Bayer has widened its pipeline in neurology, cardiology, and immunology by acquiring induced pluripotent stem cell specialist BlueRock Therapeutics.

Read more

Liquid biopsy identifies residual breast cancer

Using a platform tailored to patients’ specific cancer mutations, British and US researchers for the first time detected residual disease in breast cancer patients.

Read more

Immunic appoints Sanjay S. Patel as CFO

Immunic, Inc., a clinical-stage biopharmaceutical company focused on developing potentially best-in-class, oral therapies for the treatment of chronic inflammatory and autoimmune diseases, today announced the appointment of Sanjay S. Patel, CFA, as Chief Financial Officer, effective July 15, 2019. Mr. Patel replaces Tamara A. Seymour, who has served as the company’s Interim Chief Financial Officer since April 26, 2019.

Read more

Novo Holdings puts $72m in Lanzatech

Novo Holdings A/S (Novo Holdings) invests $72m in LanzaTech to support development of the company’s sustainable fuels and chemicals platform
Read more

Google maps for tumours and organs

German researchers have developed a software that allows to manage and correct the huge amount of data generated by 3D reconstruction of tumours or organs using light sheet microscopy.
Read more